Dose finding with escalation with overdose control (EWOC) in cancer clinical trials (Q903293)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Dose finding with escalation with overdose control (EWOC) in cancer clinical trials |
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Dose finding with escalation with overdose control (EWOC) in cancer clinical trials |
scientific article |
Statements
Dose finding with escalation with overdose control (EWOC) in cancer clinical trials (English)
0 references
5 January 2016
0 references
cancer phase I trials
0 references
dose-limiting toxicity
0 references
escalation with overdose control
0 references
tolerated dose
0 references
optimal Bayesian feasible
0 references
0 references
0 references
0.869257390499115
0 references
0.8202523589134216
0 references
0.8141714930534363
0 references
0.8110796809196472
0 references
0.8059906363487244
0 references
